Institutional investors purchased a net $568.3 thousand shares of MNOV during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 20.08% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 608.1 Thousand shares of MediciNova Inc
CUTLER GROUP LP Sold 200.00 shares of MediciNova Inc